37
Participants
Start Date
May 9, 2013
Primary Completion Date
October 12, 2015
Study Completion Date
October 12, 2015
Gadoterate meglumine
Gadoterate meglumine was administered at a dose of 0.1 mmol/kg (0.2 mL/kg) using a power injector, in an intravenous bolus at a rate of 3 mL/sec.
Guerbet Korea, Seoul
Lead Sponsor
Guerbet
INDUSTRY